Adult Vaccines Global Market Report 2025

Global Adult Vaccines Market Report 2024

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application (Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis), By End Users (Healthcare Firms, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

Name: Adult Vaccines Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Adult Vaccines Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Adult Vaccines Global Market Report 2025

Proud Members Of

Adult Vaccines Market Definition

Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases. Vaccines lessen the severity of illness in individuals who are more vulnerable, such as those with chronic health conditions or weakened immune systems.

The main types of adult vaccines are monovalent and multivalent. A monovalent vaccine refers to a vaccine that contains the mRNA component of a single virus and generates an immune response for a single antigen. The technologies involved are live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. These are used in several applications, such as influenza, dPT, the human papillomavirus, zoster, pneumococcal disease, and hepatitis, and are used by healthcare firms and hospitals

Adult Vaccines Market Segmentation

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Adult Vaccines Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Adult Vaccines Market Size 2025 And Growth Rate

The adult vaccines market size has grown strongly in recent years. It will grow from $22.82 billion in 2024 to $24.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing aging population, government vaccination programs, growing awareness of preventive healthcare, vaccine development and innovation, public health campaigns.

Adult Vaccines Market Growth Forecast

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $35.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to emergence of new infectious threats, increasing focus on immunization registries, rising threat of antimicrobial resistance, global efforts for pandemic preparedness, shift toward personalized vaccines, increased focus on maternal immunization. Major trends in the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, expanding immunization programs.

Book your 30 minutes free consultation with our research experts

Adult Vaccines Market Driver: Rising Prevalence Of Contagious Diseases Drives Growth In Adult Vaccine Market

The increasing prevalence of contagious diseases is driving the adult vaccine market forward. Contagious diseases are diseases that spread from person to person. Vaccines help the person to develop immunity against contagious diseases and therefore are a very effective mechanism for fighting infections. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in 2022, 8,300 tuberculosis cases were reported in the United States, compared with 7,874 in 2021. TB incidence during 2022 increased slightly to 2.5 per 100,000 persons, compared with 2.4 during 2021. Therefore, the increasing prevalence of contagious diseases is driving the growth of the adult vaccine market.

Adult Vaccines Market Driver: Rising Healthcare Expenditure Drives Growth In Adult Vaccine Market

The increased healthcare expenditure supported the growth of the adult vaccine market. Healthcare expenditure refers to the total cost of healthcare services provided to a population. Increased healthcare expenditure often leads to greater funding for medical research and development. By investing in vaccination programs and increasing access to vaccines, healthcare systems can reduce the burden of preventable diseases and improve overall population health. Additionally, adult vaccination can lead to significant cost savings by reducing healthcare utilization and the need for expensive treatments. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based health company, Canada's total health expenditure in 2023 is projected to reach $344 billion, which is an increase of over $9 billion compared to 2022. Therefore, the increased healthcare expenditure positively impacted the growth of the adult vaccine market.

Global Adult Vaccines Market Major Players

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Global Adult Vaccines Market Trend: Data Trend Platform To Enhance Adult Vaccination Efforts

Product innovations are a key trend gaining popularity in the adult vaccines market. Major companies in the market are introducing innovative products to sustain their position in the market. For instance, in August 2022, GSK, a UK-based biopharma company, and IQVIA, an India-based global provider of advanced analytics, technology solutions, and clinical research services, launched Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide. This resource will provide frequent and relevant data on trends to focus on and enhance public health efforts.

Global Adult Vaccines Market Trend: Merck & Co., Inc. And Moderna Collaborate To Advance Personalized Cancer Vaccine

Major companies operating in the adult vaccine market are focusing on strategic collaborations to develop and commercialize personalized cancer vaccine. Strategic collaborations are a type of business relationship in which two or more companies agree to work together to achieve common goals. For instance, in October 2022, Merck & Co., Inc., an American multinational pharmaceutical company, and Moderna, a US-based pharmaceutical and biotechnology company, entered into a collaboration to jointly develop and commercialize personalized cancer vaccine (PCV) mRNA-4157/V940 pursuant to the terms of their existing collaboration and license agreement. mRNA-4157/V940 is currently being evaluated in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with high-risk melanoma in a Phase 2 clinical trial being conducted by Moderna.

Adult Vaccines Market Merger And Acquisition: GSK Expands Vaccine Portfolio With Acquisition Of Affinivax, Inc., Strengthening Focus On Innovative Pneumococcal And Adult Vaccines

In August 2022, GSK, a UK-based pharmaceutical company, acquired Affinivax, Inc., for an undisclosed amount. This acquisition is expected to align with GSK’s strategy of building a strong portfolio of specialty medicines and vaccines, including innovative vaccine candidates for pneumococcal disease. Affinivax Inc is a US-based clinical-stage biopharmaceutical company that has developed next-generation pneumococcal vaccines and adult vaccines based on the multiple antigen presenting system (MAPS) platform technology.

Regional Analysis For The Global Adult Vaccines Market

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adult Vaccines Market?

The adult vaccines market consists of sales of mRNA vaccines and viral vector vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adult Vaccines Industry?

The adult vaccines market research report is one of a series of new reports from The Business Research Company that provides adult vaccines market statistics, including adult vaccines industry global market size, regional shares, competitors with an adult vaccines market share, detailed adult vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the adult vaccines industry. This adult vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adult Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$24.49 billion
Revenue Forecast In 2034	$35.22 billion
Growth Rate	CAGR of 9.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Vaccine Type: Monovalent, Multivalent 2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines 3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis 4) By End Users: Healthcare Firms, Hospitals Subsegments: 1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines 2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Adult Vaccines Market Characteristics

3. Adult Vaccines Market Trends And Strategies

4. Adult Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Adult Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Adult Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Adult Vaccines Market Growth Rate Analysis

5.4. Global Adult Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Adult Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Adult Vaccines Total Addressable Market (TAM)

6. Adult Vaccines Market Segmentation

6.1. Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monovalent

Multivalent

6.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Vaccines

Inactivated Viral or Bacterial Vaccines

Toxoid Vaccines

Recombinant Vaccines

Conjugate Vaccines

6.3. Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Influenza

DPT

Human Papillomavirus

Zoster

Pneumococcal

Hepatitis

6.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healthcare Firms

Hospitals

6.5. Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Antigen Vaccines

Specific Disease Vaccines

6.6. Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Vaccines

Multi-Antigen Vaccines

7. Adult Vaccines Market Regional And Country Analysis

7.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adult Vaccines Market

8.1. Asia-Pacific Adult Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adult Vaccines Market

9.1. China Adult Vaccines Market Overview

9.2. China Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adult Vaccines Market

10.1. India Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adult Vaccines Market

11.1. Japan Adult Vaccines Market Overview

11.2. Japan Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adult Vaccines Market

12.1. Australia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adult Vaccines Market

13.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adult Vaccines Market

14.1. South Korea Adult Vaccines Market Overview

14.2. South Korea Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adult Vaccines Market

15.1. Western Europe Adult Vaccines Market Overview

15.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adult Vaccines Market

16.1. UK Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adult Vaccines Market

17.1. Germany Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adult Vaccines Market

18.1. France Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adult Vaccines Market

19.1. Italy Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adult Vaccines Market

20.1. Spain Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adult Vaccines Market

21.1. Eastern Europe Adult Vaccines Market Overview

21.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adult Vaccines Market

22.1. Russia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adult Vaccines Market

23.1. North America Adult Vaccines Market Overview

23.2. North America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adult Vaccines Market

24.1. USA Adult Vaccines Market Overview

24.2. USA Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adult Vaccines Market

25.1. Canada Adult Vaccines Market Overview

25.2. Canada Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adult Vaccines Market

26.1. South America Adult Vaccines Market Overview

26.2. South America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adult Vaccines Market

27.1. Brazil Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adult Vaccines Market

28.1. Middle East Adult Vaccines Market Overview

28.2. Middle East Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adult Vaccines Market

29.1. Africa Adult Vaccines Market Overview

29.2. Africa Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adult Vaccines Market Competitive Landscape And Company Profiles

30.1. Adult Vaccines Market Competitive Landscape

30.2. Adult Vaccines Market Company Profiles

30.2.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Commonwealth Serum Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

31. Adult Vaccines Market Other Major And Innovative Companies

31.1. Johnson & Johnson

31.2. Serum Institute of India

31.3. AstraZeneca PLC

31.4. Novartis AG

31.5. Protein Sciences Corporation

31.6. Emergent BioSolutions Inc.

31.7. Bavarian Nordic A/S

31.8. Dynavax Technologies Corporation

31.9. Novavax Inc

31.10. Medimmune LLC

31.11. BioNTech SE

31.12. Moderna

31.13. Inovio Pharmaceuticals

31.14. Sinovac

31.15. Valneva Se

32. Global Adult Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adult Vaccines Market

34. Recent Developments In The Adult Vaccines Market

35. Adult Vaccines Market High Potential Countries, Segments and Strategies

35.1 Adult Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Adult Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Adult Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: GlaxoSmithKline PLC Financial Performance

Table 78: Merck & Co Financial Performance

Table 79: Sanofi Pasteur Financial Performance

Table 80: Pfizer Inc Financial Performance

Table 81: Commonwealth Serum Laboratories Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: GlaxoSmithKline PLC Financial Performance

Figure 78: Merck & Co Financial Performance

Figure 79: Sanofi Pasteur Financial Performance

Figure 80: Pfizer Inc Financial Performance

Figure 81: Commonwealth Serum Laboratories Limited Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

Power Generators Global Market Report 2023 – By Type (Gas Generator, Diesel Generator, CKD Generator), By Capacity (Below 75kva, 75375 kva, 375750 kva, Above 750 kva), By Application (Stand By, Peak Shaving, Continuous), By End User (Mining, Oil And Gas, Construction, Residential, Marine, Manufacturing, Pharmaceuticals, Commercial, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

View Report

Professional Services Market 2023 – By Type (Design, Research, Promotional And Consulting Services, Legal Services, Accounting Services), By Design, Research, Promotional And Consulting Services (Photographic Services, Market Research Services, Advertising, Public Relations, And Related Services, Scientific Research And Development Services, Environmental Consulting Services, Management Consulting Services, Specialized Design Services, Architectural, Engineering Consultants And Related Services), By Legal Services (B2B Legal Services, B2C Legal Services, Hybrid Legal Services, Criminal Law Practices), By Accounting Services (Payroll Services, Tax Preparation Services, Bookkeeping, Financial Auditing), By All Other Professional, Scientific And Technical Services, By Service Provider, By Mode, And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Software Products Global Market Report 2025 – By Type (Operating Systems & Productivity Software Publishing, Database, Storage & Backup Software Publishing, Business Analytics & Enterprise Software, Video Game Software, Design, Editing & Rendering Software), By Application (Large Enterprises, Small And Medium Enterprises), By End-User Industry (BFSI, Media And Entertainment, IT and Telecommunications, Energy And Utilities, Government And Public Sector, Retail And Consumer Goods, Manufacturing, Other End User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

IoT in Manufacturing Global Market Report 2025 – By Component (Solution, Platform, Service), By Vertical (Energy And Utilities, Automotive, Food And Beverages, Aerospace And Defense, Chemicals And Materials, High-Tech Products, Healthcare), By Platform (Device Management Platform, Application Management Platform, Connectivity Management Platform), By Application (Process Optimization, Predictive Maintenance, Asset Management, Workforce Management, Emergency And Incident Management, Logistics And Supply Chain Management, Inventory Management) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Ventricular Assist Device Global Market Report 2025 – By Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).), By Type (Pulsatile Flow, Continuous Flow), By Design (Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices), By Application (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy), By End Users (Hospital, Ambulatory Surgical Centers, Cardiology Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Electronic Design Automation Software Global Market Report 2025 – By Type (Computer-Aided Engineering (CAE), IC Physical Design And Verification, Printed Circuit Board And Multi-chip Module (PCB And MCM), Semiconductor Intellectual Property (SIP)), By Application (Communication, Consumer Electronics, Automotive, Industrial, Aerospace And Defense, Medical), By End-Use (Microprocessors And Controllers, Memory Management Units) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Network Engineering Services Global Market Report 2025 – By Service Type (Network Assessment, Network Design, Network Deployment), By Transmission Mode (Wired, Wireless), By Organization Size (Large Enterprises, Small and Medium-sized Enterprises (SMEs)), By Industry Vertical (Banking, Financial Services, and Insurance (BFSI), Telecom, Information Technology, Healthcare, Education, Media and Entertainment, Energy and Utilities, Manufacturing, Other Industry Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Product Engineering Services Global Market Report 2025 – By Service Type (Product and Component Design, Process Engineering, Maintenance, Repair and Operations, Other Service Types), By Organization Size (SMEs, Large Enterprises), By Verticals (Automotive and Transportation, Aerospace and Defense, Healthcare, IT and Telecom, Industrial Manufacturing, Energy and utilities, Media and entertainment, BFSI, Other Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the adult vaccines market?

How will the adult vaccines market drivers and restraints affect the adult vaccines market dynamics? What forces will shape the adult vaccines industry going forward?

The adult vaccines market major growth driver - Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases. Vaccines lessen the severity of illness in individuals who are more vulnerable, such as those with chronic health conditions or weakened immune systems.. For further insights on the adult vaccines market, request a sample here

What is the forecast market size or the forecast market value of the adult vaccines market?

The adult vaccines market size has grown strongly in recent years. It will grow from $22.82 billion in 2024 to $24.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing aging population, government vaccination programs, growing awareness of preventive healthcare, vaccine development and innovation, public health campaigns. The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $35.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to emergence of new infectious threats, increasing focus on immunization registries, rising threat of antimicrobial resistance, global efforts for pandemic preparedness, shift toward personalized vaccines, increased focus on maternal immunization. Major trends in the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, expanding immunization programs. For further insights on the adult vaccines market, request a sample here

How is the adult vaccines market segmented?

The adult vaccines market is segmented
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen VaccinesFor further insights on the adult vaccines market, request a sample here

Which region has the largest share of the adult vaccines market? What are the other regions covered in the report?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the adult vaccines market, request a sample here.

Who are the major players in the adult vaccines market?

What are the key trends in the adult vaccines market?

Major trend in the adult vaccines market - Data Trend Platform To Enhance Adult Vaccination Efforts. For further insights on the adult vaccines market, request a sample here.

What are the major opportunities in the adult vaccines market? What are the strategies for the adult vaccines market?

For detailed insights on the major opportunities and strategies in the adult vaccines market, request a sample here.

How does the adult vaccines market relate to the overall economy and other similar markets?

For detailed insights on adult vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the adult vaccines industry?

For detailed insights on the mergers and acquisitions in the adult vaccines industry, request a sample here.

What are the key dynamics influencing the adult vaccines market growth? SWOT analysis of the adult vaccines market.

For detailed insights on the key dynamics influencing the adult vaccines market growth and SWOT analysis of the adult vaccines industry, request a sample here.